L’entreprise a fait l’acquisition des droits de propriété intellectuelle de Merck relatifs à la technologie OPV et les mettra à disposition de ses concurrents et partenaires, via des accords de licence.
This website uses cookies to anonymously count visitor numbers. To find out more, please see our Data Protection Policy.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.